Background and Aims:The Quzhi formula,a Chinese med-icine compound prescription,relieves nonalcoholic steato-hepatitis(NASH)symptoms.This study aimed to explore the mechanism of the Quzhi formula against NASH.Methods:...Background and Aims:The Quzhi formula,a Chinese med-icine compound prescription,relieves nonalcoholic steato-hepatitis(NASH)symptoms.This study aimed to explore the mechanism of the Quzhi formula against NASH.Methods:A choline-deficient,L-amino acid-defined,high-fat diet induced a NASH mouse model and a free fatty acid-induced mouse hepatocyte cell model were used to evaluate the function of Quzhi formula in vivo and in vitro.Network pharmacol-ogy and molecular docking technology were performed to uncover the possible protective mechanisms of the Quzhi formula against NASH.Key factors in liver lipid metabolism and endoplasmic reticulum(ER)stress pathway were evalu-ated to verify the mechanism.Results:The positive contri-bution of the Quzhi formula on NASH was confirmed in vivo and in vitro.Abnormal accumulation of lipid in the liver and inflammatory responses were significantly decreased by the Quzhi formula.Network pharmacological analysis and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis showed that the Quzhi formula protected against NASH by regulating ER stress and inflammatory responses,which was enhanced by further molecular docking analy-sis.In addition,mechanism exploration showed that Quzhi formula mainly reduced ER stress by downregulating Bip/eIF2αsignaling.Conclusions:The Quzhi formula protected against NASH by inhibiting lipid accumulation,ER stress,and inflammatory responses,which supports the potential use of Quzhi formula as an alternative treatment for NASH.展开更多
目的:观察曲直汤加味联合塞来昔布治疗肝肾亏虚型膝骨关节炎的临床效果。方法:将60例膝骨关节炎患者按随机数字表法分为对照组和观察组,每组各30例,分别给予塞来昔布和曲直汤加味联合塞来昔布治疗,疗程均为4周。观察西安大略和麦克马斯...目的:观察曲直汤加味联合塞来昔布治疗肝肾亏虚型膝骨关节炎的临床效果。方法:将60例膝骨关节炎患者按随机数字表法分为对照组和观察组,每组各30例,分别给予塞来昔布和曲直汤加味联合塞来昔布治疗,疗程均为4周。观察西安大略和麦克马斯特大学骨关节炎指数值(Western Ontario and Mc Master University osteoarthritis index,WOMAC)、膝关节功能量表(Lysholm)和视觉模拟疼痛量表(visual analogue scale,VAS)治疗前后的数值变化及临床疗效。结果:治疗后,两组患者WOMAC指数、VAS评分显著下降,Lysholm评分明显提高,且观察组显著优于对照组(P<0.05);观察组总有效率为96.67%,明显高于对照组的73.33%(P<0.05)。结论:与单用塞来昔布相比,曲直汤加味联合塞来昔布可进一步减轻患者的临床症状,提高膝关节的功能,显著改善患者的生活质量。展开更多
基金Shanghai to further Accelerate the Development of TCM of Three-Year Action Plan(ZY3-CC-CX-3-3035)Appropriate Technology Promotion Project of Shanghai Health Commission(2013SY072).
文摘Background and Aims:The Quzhi formula,a Chinese med-icine compound prescription,relieves nonalcoholic steato-hepatitis(NASH)symptoms.This study aimed to explore the mechanism of the Quzhi formula against NASH.Methods:A choline-deficient,L-amino acid-defined,high-fat diet induced a NASH mouse model and a free fatty acid-induced mouse hepatocyte cell model were used to evaluate the function of Quzhi formula in vivo and in vitro.Network pharmacol-ogy and molecular docking technology were performed to uncover the possible protective mechanisms of the Quzhi formula against NASH.Key factors in liver lipid metabolism and endoplasmic reticulum(ER)stress pathway were evalu-ated to verify the mechanism.Results:The positive contri-bution of the Quzhi formula on NASH was confirmed in vivo and in vitro.Abnormal accumulation of lipid in the liver and inflammatory responses were significantly decreased by the Quzhi formula.Network pharmacological analysis and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis showed that the Quzhi formula protected against NASH by regulating ER stress and inflammatory responses,which was enhanced by further molecular docking analy-sis.In addition,mechanism exploration showed that Quzhi formula mainly reduced ER stress by downregulating Bip/eIF2αsignaling.Conclusions:The Quzhi formula protected against NASH by inhibiting lipid accumulation,ER stress,and inflammatory responses,which supports the potential use of Quzhi formula as an alternative treatment for NASH.
文摘目的:观察曲直汤加味联合塞来昔布治疗肝肾亏虚型膝骨关节炎的临床效果。方法:将60例膝骨关节炎患者按随机数字表法分为对照组和观察组,每组各30例,分别给予塞来昔布和曲直汤加味联合塞来昔布治疗,疗程均为4周。观察西安大略和麦克马斯特大学骨关节炎指数值(Western Ontario and Mc Master University osteoarthritis index,WOMAC)、膝关节功能量表(Lysholm)和视觉模拟疼痛量表(visual analogue scale,VAS)治疗前后的数值变化及临床疗效。结果:治疗后,两组患者WOMAC指数、VAS评分显著下降,Lysholm评分明显提高,且观察组显著优于对照组(P<0.05);观察组总有效率为96.67%,明显高于对照组的73.33%(P<0.05)。结论:与单用塞来昔布相比,曲直汤加味联合塞来昔布可进一步减轻患者的临床症状,提高膝关节的功能,显著改善患者的生活质量。